Abstract:Enzymatic asymmetric sulfoxidation using molecular oxygen as the oxidant is a promising green chemistry approach to chiral sulfoxide production. Despite the broad substrate spectrum of cyclohexanone monooxygenases (CHMOs), some unnatural substrates with bulky functional groups, such as the pharmaceutically relevant omeprazole sulfide, cannot be effectively accepted by CHMOs. Herein, we describe a set of variants derived from an Acinetobacter calcoaceticus CHMO (AcCHMO), whose active sites adjacent to the substrate tunnel were altered to shift the substrate specificity from cyclohexanone monooxygenation toward omeprazole sulfide sulfoxidation. We performed homologous modeling and molecular docking to identify key residues that might affect the substrate specificity. Two libraries of residues lining the active center of AcCHMO were then constructed and screened by an effective halo-based selection method using the solubility difference between the substrate (omeprazole sulfide) and product (esomeprazole). Functional evaluation of the resultant variants showed that the substrate specificity of AcCHMO was markedly altered from the small natural substrate (cyclohexanone) toward the desired bulky substrate (omeprazole sulfide) despite the extremely poor activity detected even for the best variant, M2 (0.61 U/g(prot)). The crystal structure of M2 complexed with a flavin adenine dinucleotide (FAD) prosthetic group was determined, which provided insight into the altered substrate specificity. To improve the activity of enzyme M2 toward pharmaceutical precursor omeprazole sulfide, we performed both local and global protein engineering among the two CASTing libraries surrounding FAD(+) and NADP(+) prosthetic groups and an error-prone PCR library of the full-length AcCHMO. As a result, variant M6 was obtained, giving a 50-fold higher activity compared to M2. This structure-guided protein engineering of AcCHMO provided a promising candidate for converting omeprazole sulfide into (S)-omeprazole using a green biocatalytic method.

"Top" or "bottom" switches of a cyclohexanone monooxygenase controlling the enantioselectivity of the sandwiched substrate.

The Mutagenesis of a Single Site for Enhancing or Reversing the Enantio- or Regiopreference of Cyclohexanone Monooxygenases

Customizing the Enantioselectivity of a Cyclohexanone Monooxygenase by a Strategy Combining “size‐probes” with in Silico Study

Switching the Chemoselectivity of Perakine Reductase for Selective Reduction of Α,β-Unsaturated Ketones by Arg127 Mutation.

Photoinduced Promiscuity of Cyclohexanone Monooxygenase for the Enantioselective Synthesis of Α‐fluoroketones

Identification two key residues at the intersection of domains of a thioether monooxygenase for improving its sulfoxidation performance

Exploiting Cofactor Versatility to Convert a FAD‐Dependent Baeyer–Villiger Monooxygenase into a Ketoreductase

Structure-guided Stereoselectivity Inversion of a Short-Chain Dehydrogenase/reductase Towards Halogenated Acetophenones.

Towards practical Baeyer-Villiger-monooxygenases: design of cyclohexanone monooxygenase mutants with enhanced oxidative stability

Exploring the enantioselective mechanism of halohydrin dehalogenase from Agrobacterium radiobacter AD1 by iterative saturation mutagenesis.

Switchable Stereoselectivity in Bromoaminocyclization of Olefins Catalyzed by Brønsted Acids of Anionic Chiral CoIII Complexes.

Switchable Stereoselectivity in Bromoaminocyclization of Olefins: Using Brønsted Acids of Anionic Chiral Cobalt(III) Complexes.

Flipping the Substrate Creates a Highly Selective Halohydrin Dehalogenase for the Synthesis of Chiral 4-Aryl-2-oxazolidinones from Readily Available Epoxides

Precise regulation of the substrate selectivity of Baeyer-Villiger monooxygenase to minimize overoxidation of prazole sulfoxides

Characterization and Crystal Structure of a Robust Cyclohexanone Monooxygenase

Engineering of a Baeyer‐Villiger monooxygenase to improve substrate scope, stereoselectivity and regioselectivity

Altering the substrate specificity and enantioselectivity of phenylacetone monooxygenase by structure-inspired enzyme redesign

Photoinduced Promiscuity of Cyclohexanone Monooxygenase for the Enantioselective Synthesis of Α-Deuterated Carbonyl Compounds

Improving the Enantioselectivity of CHMOBrevi1 for Asymmetric Synthesis of Podophyllotoxin Precursor.

Reversible control of enantioselectivity by the length of ketone substituent in biocatalytic reduction

Engineering of Cyclohexanone Monooxygenase for the Enantioselective Synthesis of (S)-Omeprazole